Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. It operates through three segments: Hong Kong, Mainland China, and Overseas. The company offers Chinese medical consultation and treatment services. It also operates retail outlets in H… Read more
Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) - Total Liabilities
Latest total liabilities as of June 2025: $312.26 Million USD
Based on the latest financial reports, Beijing Tong Ren Tang Chinese Medicine Company Limited (BJTRF) has total liabilities worth $312.26 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Beijing Tong Ren Tang Chinese Medicine Company Limited - Total Liabilities Trend (2015–2024)
This chart illustrates how Beijing Tong Ren Tang Chinese Medicine Company Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Beijing Tong Ren Tang Chinese Medicine Company Limited Competitors by Total Liabilities
The table below lists competitors of Beijing Tong Ren Tang Chinese Medicine Company Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ohio Valley Banc Corp
NASDAQ:OVBC
|
USA | $1.41 Billion |
|
Designer Brands Inc
NYSE:DBI
|
USA | $1.75 Billion |
|
Xuchang Ketop Testing Research Ins
SHE:003008
|
China | CN¥45.68 Million |
|
Westwing Group AG
F:WEW
|
Germany | €129.20 Million |
|
308430
KQ:308430
|
Korea | ₩5.69 Billion |
|
Guangdong Yantang Dairy Co Ltd
SHE:002732
|
China | CN¥469.76 Million |
|
Newbury Street II Acquisition Corp Class A Ordinary Shares
NASDAQ:NTWO
|
USA | $6.16 Million |
|
Washington Real Estate Investment Trust
F:WRI
|
Germany | €777.68 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Beijing Tong Ren Tang Chinese Medicine Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 18.17 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Tong Ren Tang Chinese Medicine Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Tong Ren Tang Chinese Medicine Company Limited (2015–2024)
The table below shows the annual total liabilities of Beijing Tong Ren Tang Chinese Medicine Company Limited from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $40.29 Million | -23.95% |
| 2023-12-31 | $52.97 Million | -18.31% |
| 2022-12-31 | $64.85 Million | +58.35% |
| 2021-12-31 | $40.95 Million | +3.48% |
| 2020-12-31 | $39.57 Million | -17.26% |
| 2019-12-31 | $47.83 Million | +155.00% |
| 2018-12-31 | $18.76 Million | -3.83% |
| 2017-12-31 | $19.51 Million | +18.53% |
| 2016-12-31 | $16.46 Million | +8.02% |
| 2015-12-31 | $15.23 Million | -- |